Katzman R, Kang D, Thomas R
Department of Neurosciences and the Alzheimer Disease Research Center, University of California at San Diego, La Jolla 92037, USA.
Neurochem Res. 1998 Mar;23(3):369-76. doi: 10.1023/a:1022461601609.
The Apolipoprotein E4 allele (Apo-epsilon4) is the major susceptibility gene for late onset Alzheimer Disease (AD) but epidemiological data suggest that the effect of this allele is modified in different individuals by genetic or environmental factors. Age and head injury are major non-genetic factors modifying the Apo-epsilon4 risk. There is conflicting data as to whether alleles of other chaperon proteins (such as alpha-1-antichymotrypsin (ACT)) or Apo-epsilon4 receptors (such as the VDRL receptor) modify the Apo-epsilon4 risk for AD. We analyze problems posed by genetic association studies including those of multiple comparisons and selection of controls, the latter problem exacerbated by the wide variations in Apolipoprotein E allele frequencies observed in different groups and localities.
载脂蛋白E4等位基因(Apo-ε4)是晚发性阿尔茨海默病(AD)的主要易感基因,但流行病学数据表明,该等位基因的效应在不同个体中会受到遗传或环境因素的影响。年龄和头部损伤是改变Apo-ε4风险的主要非遗传因素。关于其他伴侣蛋白(如α-1-抗糜蛋白酶(ACT))或Apo-ε4受体(如VDRL受体)的等位基因是否会改变AD的Apo-ε4风险,存在相互矛盾的数据。我们分析了基因关联研究中出现的问题,包括多重比较和对照选择问题,在不同群体和地区观察到的载脂蛋白E等位基因频率的广泛差异加剧了后一个问题。